Verona Pharma

Developer of drugs for the treatment of respiratory diseases such as asthma, COPD

placeLondon, England, United Kingdom calendar_todayFounded 2005 groups27 employees language veronapharma.com

Registered entities

Innovation

37 patent families (13 granted) — focus: Human necessities, Chemistry & metallurgy; filing pace steady. Cited 1,764 times.

YearFilings
20156
20168
20176
20187
20196
20207
202110
20227
20238
202412
202516
20263

Social engagement

Social engagement: 23K social following, 9 posts in the last 12 months — below the industry typical range.

Investor mix

22 investors on record; 2 have since exited.

Investor typeCountShare
Venture capital1150%
Private equity627%
Bank & private debt29%
Other / undisclosed314%

Hiring activity

No recent openings observed

No roles tracked in the last 12 months

12 Jun 2025 · Sr Clinical Trial Manager · Raleigh

30 May 2025 · Medical Science Liaison · Carmel

11 Mar 2025 · Director, Pharmacovigilance · Raleigh

17 Jan 2025 · Director, Contract Management and Development Outsourcing · null

6 Jan 2025 · Accounts Payable Associate · Raleigh

Based on job postings tracked across public sources.

Recent activity

16 Oct 2025
Event
CHEST25
28 Sep 2025
Event
European Respiratory Society (#ERS) Congress
24 Sep 2025
Recognition
Coming soon